20
A. Tai et al. / Journal of Molecular Catalysis B: Enzymatic 92 (2013) 19–23
into a 2.0 ml screw cap micro tube (Fukae Kasei, Kobe, Japan), after
which 950 l of 50 mM acetate buffer (pH 4.0–5.5) was added. After
addition of Toruzyme 3.0 L (50 l), the mixture was placed in a
thermoregulated shaker (M·BR-022, TAITEC, Saitama, Japan) and
was stirred at 1100 r/min for 24 h at 35–60 ◦C. After 24 h, the reac-
tion mixture was diluted 100-fold with 80% acetonitrile–50 mM
ammonium acetate and then centrifuged. Ten l of the resulting
supernatant was subjected to HPLC analysis. HPLC analysis was
carried out by a modification of our previous method [23]. Separa-
tion for transglycosylation products of EA was achieved by isocratic
elution on an Inertsil Diol column (ꢀ 4.6 mm × 250 mm, 5 m, GL
Sciences Inc., Tokyo) kept at 40 ◦C with 80% acetonitrile–50 mM
ammonium acetate at a flow rate of 0.7 ml/min. The absorbance
at 260 nm was monitored. The reaction yield of monoglucosy-
lated products of EA was determined quantitatively as AA-2G
equivalent.
2.4. Addition of amyloglucosidase to the glycosylation reaction
mixture
Fig. 1. Chemical structures of AA, AA-2G, EA and EA-2G.
described above by using AA-2G and that the stable EA derivative
of EA. It has been reported that a stable EA derivative, 2-O-␣-d-
glucopyranosyl-d-erythorbic acid (EA-2G, Fig. 1), was synthesized
from EA and ␣-cyclodextrin by a transglucosylation with CGTase
from B. stearothermophilus [22]. This synthesis was fundamentally
based on the method of AA-2G synthesis [7], and the yield (ca. 10%)
of EA-2G was lower than that (ca. 40%) of AA-2G. Hence, in this
study, we established conditions for specific and efficient formation
of EA-2G by using commercially available enzymes, and we found
that this method is superior to the previous method in terms of
reaction efficiency in large-scale production.
EANa monohydrate (30 mg, 139 mol) and ␣- or ␥-cyclodextrin
(60.5 mol) were put into a 2.0 ml screw cap micro tube, after
which 950 l of 50 mM acetate buffer (pH 4.0) was added. After
addition of Toruzyme 3.0 L (50 l), the mixture was placed in a
thermoregulated shaker and was stirred at 1100 r/min for 24 h at
40 ◦C. After 24 h reaction, the temperature of the reaction mixture
was raised to 60 ◦C and 50 l of amyloglucosidase (1000 units/ml)
was added. Then the resulting mixture was stirred at 1100 r/min
for 8 h at 60 ◦C. Aliquots of 50 l were withdrawn at the indicated
times, diluted 100-fold with 80% acetonitrile–50 mM ammonium
acetate, and then centrifuged. Ten l of the resulting supernatant
was subjected to HPLC analysis.
2. Experimental
2.5. Preparation and purification of
2-O-˛-d-glucopyranosyl-d-erythorbic acid
2.1. General experimental procedure
1H NMR, 13C NMR and 2D NMR spectra were recorded on a
Varian NMR System 600 MHz instrument. Electron spray ioniza-
tion (ESI) high-resolution mass spectra were obtained on a Bruker
Daltonics MicrOTOF II instrument using direct sample injection.
Optical rotations were obtained at JASCO DIP-1000. The HPLC anal-
yses were carried out with a system consisting of a Hitachi L-2130
pump, L-2420 UV-VIS detector, L-2300 column oven, and D-2500
chromato-integrator (Hitachi High-Technologies, Tokyo, Japan).
EANa monohydrate (3.00 g, 13.9 mmol) and ␥-cyclodextrin
(7.86 g, 6.06 mmol) were dissolved in 100 ml of 50 mM acetate
buffer (pH 4.0). Toruzyme 3.0 L (5 ml) was added to the solution. The
mixture was stirred for 24 h at 40 ◦C. After checking the progress
of the reaction by HPLC, the temperature of the reaction mixture
was raised to 60 ◦C and 5 ml of amyloglucosidase (1000 units/ml)
was added. Then the resulting mixture was stirred for 2 h at 60 ◦C.
The reaction mixture was chromatographed on a DOWEX 1 × 8 col-
umn (ꢀ 4.6 cm × 24.5 cm, Acetate form, Muromachi Technos, Tokyo,
Japan) eluted with a stepwise gradient of acetic acid–H2O solvent
system (0, 0.1, 0.3, 1 and 3 M). The monoglucoylated erythorbic
acid-containing fraction (3 M acetic acid eluate) was concentrated
to dryness. The resulting residue dissolved in 0.5% formic acid solu-
tion was further chromatographed on a Toyopearl HW-40F column
(ꢀ 4.6 cm × 29 cm, Tosoh, Tokyo, Japan) eluted with 0.5% formic
acid solution. The major glucosylated erythorbic acid-containing
fraction was repeatedly purified by a Toyopearl HW-40F column
(ꢀ 2.5 cm × 95 cm) to yield 2-O-␣-d-glucopyranosyl-d-erythorbic
acid (2.31 g, 49.1%). 1H NMR (600 MHz, D2O-CD3OD (3:1)) ıH: 3.25
(1H, t, J = 9.6 Hz, H-4ꢀ), 3.41 (1H, dd, J = 3.6, 9.6 Hz, H-2ꢀ), 3.50 (2H,
m, H-6), 3.54 (2H, m, H-6ꢀ), 3.61 (1H, t, J = 9.6 Hz, H-3ꢀ), 3.74 (1H,
dd, J = 3.3, 9.6 Hz, H-5ꢀ), 3.93 (1H, m, H-5ꢀ), 4.79 (1H, d, J = 3.0 Hz,
H-4), 5.30 (1H, d, J = 3.6 Hz, H-1ꢀ). 13C NMR (150 MHz, D2O-CD3OD
(3:1)) ıC: 61.1 (C-6ꢀ), 62.4 (C-6), 70.0 (C-4ꢀ), 71.8 (C-5), 72.2 (C-2ꢀ),
73.6 (C-3ꢀ), 74.1 (C-5ꢀ), 78.8 (C-4), 100.0 (C-1ꢀ), 118.8 (C-2), 163.7
2.2. Chemicals
Cyclodextrin glucanotransferase from Thermoanaerobacter sp.
(Toruzyme 3.0 L, batch ACN00261) was kindly provided by
Novozymes (Bagsvaerd, Denmark). Amyloglucosidase solution
from Aspergillus niger (A9913, 4000 units/ml) was purchased from
Sigma Chemical (St. Louis, MO). Erythorbic acid sodium salt (EANa)
monohydrate was from Tokyo Chemical Industry (Tokyo, Japan). ␣-
Cyclodextrin, -cyclodextrin and ␥-cyclodextrin were from Wako
Pure Chemical Industries (Osaka, Japan). 2-O-␣-d-glucopyranosyl-
l-ascorbic acid (AA-2G) was a gift from Hayashibara Biochemical
Laboratories, Inc. (Okayama, Japan). Reagents were used without
further purification. All water used was Milli-Q grade.
2.3. Optimization of reaction conditions for transglycosylation
(C-3), 173.0 (C-1). ESI-HRMS m/z [M−H]−: calcd. for C12H17O11
:
EANa monohydrate (10–100 mg, 46.3–463 mol) and cyclodex-
trin (0.22–0.66 times to the mole of EANa monohydrate) were put
337.0776, found 337.0777. [␣]18 +151.6◦ (c 0.9, H2O).
D